Intercept Pharma Is One Step Closer to Filing for Approval of First NASH Treatment
Intercept Pharma plans to seek regulatory approval in the U.S. and Europe in the second half of this year.
Intercept Pharma plans to seek regulatory approval in the U.S. and Europe in the second half of this year.